/drug-combination-safety

Not medical advice. Speak with a healthcare professional before using any medication.


Feel confident about your treatment — learn what’s safe.
Contact UsWhether testosterone and insulin may be used together depends on individual patient factors, and a prescriber should assess appropriateness and establish a monitoring plan. According to Lexicomp, testosterone and insulin are not known to have a direct pharmacokinetic interaction; however, per FDA-approved labeling, testosterone may influence insulin sensitivity, which is clinically relevant for patients managing blood glucose with insulin.
Per FDA-approved labeling, insulin lowers blood glucose by facilitating cellular glucose uptake. Testosterone affects muscle mass, fat distribution, red blood cell production, mood, and libido through androgen receptors. These pathways are distinct, but testosterone's effects on body composition and metabolic parameters may secondarily influence how the body responds to insulin in some individuals.
Patients using insulin who initiate testosterone therapy should work with their prescriber to establish an appropriate glucose monitoring schedule. Insulin dose adjustments may be needed if sensitivity changes are observed.
Patients should not adjust their insulin regimen without prescriber guidance, as insulin dose changes carry hypoglycemia risk.
Compounded medications are not FDA-approved. A licensed prescriber should determine whether any compounded preparation is appropriate based on individual patient needs.
Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. FDA-approved medications should be considered first when commercially available options meet patient needs. Compounded preparations are prepared by licensed pharmacists in response to valid prescriptions for individual patients. Interaction and safety information on this page is based on FDA-approved formulations and may not fully apply to compounded preparations, which differ in formulation and regulatory status.
Common
Mild
Per FDA-approved labeling for testosterone products, changes in insulin sensitivity are a recognized clinical consideration. Testosterone may increase cellular insulin sensitivity in some patients, which may result in lower-than-expected blood glucose readings, particularly after dosing or meals. Consult a clinician if blood glucose patterns change significantly after starting testosterone.
Normally lasts for:
0.5–3 hours
Common
Moderate
Per FDA-approved labeling, testosterone therapy is associated with acne and increased sebum production. These androgen-driven skin changes may occur regardless of concurrent insulin use. More noticeable breakouts or increased skin oiliness may develop, particularly early in therapy. Consult a clinician if acne is persistent or causing significant concern.
Normally lasts for:
12–24 hours
Common
Mild
Per FDA-approved labeling, testosterone therapy may be associated with mood-related effects including irritability. Blood glucose variability related to insulin can also affect mood. Feelings of irritability, emotional variability, or mood instability may occur as hormone and glucose levels adjust. Consult a clinician if mood changes are persistent or impairing daily functioning.
Normally lasts for:
2–6 hours
Common
Mild
Per prescribing information, changes in appetite may occur with hormone therapy. Blood glucose variability from insulin can also influence hunger signals. Increased hunger, particularly associated with lower blood sugar episodes, may be noted. Consult a clinician if appetite changes are significant or associated with glucose instability.
Normally lasts for:
1–3 hours
Uncommon
Mild
Per FDA-approved labeling, testosterone therapy is associated with fluid retention and edema. Mild water retention or puffiness, particularly in the ankles or extremities, may occur. Consult a clinician if swelling is persistent, worsening, or accompanied by cardiovascular symptoms.
Normally lasts for:
12–24 hours
Uncommon
Moderate
Per FDA-approved labeling, headache is a recognized adverse effect of testosterone therapy. Blood glucose fluctuations associated with insulin management can also contribute to headaches. Intermittent headaches may occur, particularly during the period when hormone levels and insulin sensitivity are adjusting. Consult a clinician if headaches are frequent, severe, or do not resolve as doses stabilize.
Important labeled warning: Per FDA-approved labeling, testosterone carries warnings for polycythemia (increased red blood cell count), cardiovascular events, liver toxicity, and venous thromboembolism. Regular monitoring by a prescriber is essential. Consult a clinician if you have concerns about these risks.
Normally lasts for:
1–4 hours
Need Help Taking This the Right Way?
Quick, caring advice from pharmacists who know these medications inside out.

This page provides educational information only and is not a substitute for professional medical advice. If you have concerns after taking testosterone alongside insulin, contact your prescriber or pharmacist for guidance specific to your situation.
Symptoms that warrant prompt contact with a clinician:
Seek emergency care if any of the following occur:
Do not adjust your insulin dose without prescriber guidance, as this carries a risk of hypoglycemia or hyperglycemia.
Let’s talk — we focus on your unique needs, with support you can trust.
Testosterone is an endogenous androgen hormone. Per FDA-approved labeling, it acts through androgen receptors to support energy, sexual wellbeing, muscle tone, and metabolic function. According to Lexicomp, when used alongside insulin, the primary clinical consideration is testosterone's potential influence on insulin sensitivity — per published literature cited in Lexicomp, testosterone may improve cellular responsiveness to insulin in some patients, which can secondarily affect glucose management. A prescriber should determine how this interaction applies to the individual patient's diabetes or glucose management plan and establish appropriate monitoring.
Per FDA-approved labeling, insulin is a hormone that facilitates glucose uptake into cells, lowering blood glucose concentration. It acts through insulin receptors on cells, functioning as the primary regulator of blood sugar. According to Lexicomp, insulin's pharmacokinetic profile is not expected to be directly altered by testosterone. However, because testosterone may affect body composition and cellular responsiveness to insulin in some patients per published data, insulin requirements may change over the course of testosterone therapy. Prescribers typically monitor glucose trends and adjust insulin doses accordingly when hormonal therapy is initiated or modified.
Talk with us — we’ll walk through your unique situation and support you in feeling confident about your hormone journey.
Does testosterone affect insulin sensitivity?
According to Lexicomp and published literature cited in clinical pharmacology references, testosterone at physiologic replacement doses may support insulin sensitivity in some women by improving lean muscle mass and metabolic parameters. Per FDA-approved labeling, testosterone effects on body composition are recognized, and changes in insulin sensitivity are a clinical consideration.
This is not a universal effect, and the degree of benefit or change varies by individual. A prescriber should monitor glucose trends and relevant labs and adjust insulin doses if consistent changes in sensitivity are observed.
Does insulin change testosterone levels?
Per prescribing information and published literature cited in Lexicomp, well-controlled insulin therapy at appropriate doses is not expected to substantially alter testosterone levels in most patients. The relationship between insulin and androgen levels is more commonly observed in the context of chronic hyperinsulinemia (such as in insulin resistance), where elevated insulin may influence ovarian androgen production.
Does testosterone therapy impact blood sugar?
Per FDA-approved labeling and data cited in Lexicomp, testosterone at standard physiologic doses may modestly improve insulin sensitivity in some patients, contributing to more stable glucose responses over time. Major blood sugar swings are not a typical expected effect of appropriate testosterone therapy; however, individual metabolic responses vary.
A prescriber should assess glucose trends when testosterone therapy is initiated or adjusted. Patients should report unusual fatigue, shakiness, or unexpected glucose readings to their clinician rather than adjusting insulin independently.
Does low testosterone cause insulin resistance?
Per published literature cited in Lexicomp, low testosterone has been associated with reduced insulin sensitivity and changes in metabolic parameters in some studies. Restoring testosterone to a physiologic range may be associated with improved insulin sensitivity in some patients, though individual responses vary and this is not an established universal effect.
Per FDA-approved prescribing information, any hormonal therapy that influences body composition or metabolic function should be undertaken with appropriate monitoring. A prescriber should determine whether testosterone therapy is appropriate in the context of existing glucose management and establish a monitoring plan for relevant lab values.
Ask your prescriber whether a compounded option is appropriate for you. Contact Voshell's Pharmacy for customized compounding support.